Home / Share Price Target / Titanbio
Titan Biotech Share Price Target 2024, 2025, 2026 to 2039 With Charts
Titan Biotech Limited | |||
 | Symbol: TITANBIO | ||
| Price: ₹584.25 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Titan Biotech Financial Performance
- 0.1.1: Is Titan Biotech A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Titan Biotech Share Price Target For 2024
- 1.1.1: Titan Biotech Share Price Target Table For 2024
- 1.1.2: Summary: Titan Biotech Share Price Prediction For 2024
- 1.2: Titan Biotech Share Price Target For 2025
- 1.2.1: Titan Biotech Share Price Target Table For 2025
- 1.2.2: Summary: Titan Biotech Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Titan Biotech Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Titan Biotech Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Titan Biotech Past Performance
Advertisement
Titan Biotech Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 419.17 Crore | Market valuation of Titan Biotech's shares. |
| Revenue (TTM) | 143.99 Crore | Total revenue generated by Titan Biotech over the past twelve months. |
| Net Income (TTM) | +24.84 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 20.04% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 51.47% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +5.87% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 0.07 | Company's total debt divided by total shareholder equity. |
| Total Debt | 8.56 Crore | Sum of Titan Biotech's current & long-term financial obligations. |
Is Titan Biotech A Good Buy For Long Term?
Titan Biotech's strong financial performance, with a 51.47% profit margin and consistent revenue growth of 5.87% in the last quarter, indicates its potential as a long-term investment. The company's impressive past returns, including a 131.78% return over the last year and a 264.59% return over the last 3 years, further support its growth trajectory. However, it's important to note the company's debt of 8.56 Crore, which may require further analysis to assess its impact on future profitability. Overall, Titan Biotech appears to be a promising investment opportunity for long-term investors seeking growth potential.
To predict the Titan Biotech's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Titan Biotech Share Price Target For 2024
The line chart displays the monthly closing prices of Titan Biotech with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Titan Biotech shares in 2024, see the table below.
Advertisement
Titan Biotech Share Price Target Table For 2024
| Titan Biotech's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 602.00 (+3.03%) | Price Action: 27 Aug 2024 High |
| 2024 Target 2 | 595.79 (+1.97%) | Price Action: 01 Aug 2024 High |
| 2024 Target 1 | 588.90 (+0.79%) | Price Action: Jul 2024 High |
| Current Price | 584.25 | Titan Biotech's 1 share price as of Fri 06 Sep 2024 |
| Stop Loss 1 | 582.00 (-0.39%) | Price Action: 29 Aug 2024 Low |
| Stop Loss 2 | 576.00 (-1.42%) | Price Action: 21 Aug 2024 Low |
| Stop Loss 3 | 570.00 (-2.44%) | Price Action: 03 Sep 2024 Low |
Summary: Titan Biotech Share Price Prediction For 2024
In summary, Titan Biotech has surged by ₹174.65, achieving a notable +42.64% increase from 1st January 2024 to 06 Sep 2024. Our analysis of Titan Biotech for 2024 predicts an additional rise of 0.79% to 3.03% by the end of 2024 with three potential targets T1: 588.90, T2: 595.79, T3: 602.00. Stop Loss at SL1: 582.00, SL2: 576.00, SL3: 570.00.
Titan Biotech has a 52-week high of ₹645.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹325.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Titan Biotech.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Titan Biotech Share Price Target For 2025
The line chart displays the monthly closing prices of Titan Biotech with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Titan Biotech shares in 2025, see the table below.
Advertisement
Titan Biotech Share Price Target Table For 2025
| Titan Biotech's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 864.97 (+48.04%) | Price Action: Chart |
| 2025 Target 2 | 848.84 (+45.28%) | Price Action: Chart |
| 2025 Target 1 | 840.44 (+43.84%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 584.25 | Titan Biotech's 1 share price as of Fri 06 Sep 2024 |
| Stop Loss 1 | 520.45 (-10.92%) | Technical Indicator: MA200 |
| Stop Loss 2 | 515.04 (-11.85%) | Price Action: Apr 2024 Low |
| Stop Loss 3 | 505.77 (-13.44%) | Price Action: Chart |
Summary: Titan Biotech Share Price Prediction For 2025
In summary, Titan Biotech has surged by ₹174.65, achieving a notable +42.64% increase from 1st January 2024 to 06 Sep 2024. Our analysis of Titan Biotech for 2025 predicts an additional rise of 43.84% to 48.04% by the end of 2025 with three potential targets T1: 840.44, T2: 848.84, T3: 864.97. Stop Loss at SL1: 520.45, SL2: 515.04, SL3: 505.77.
Titan Biotech has a All-Time high of ₹645.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹325.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Titan Biotech, we have created a specific page for that check here: Titan Biotech Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Titan Biotech Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Titan Biotech share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 15.2% over the next 15 years.
For complete year by year Titan Biotech long term share price target from 2024, 2025 to 2039 check the below table.
Titan Biotech Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Titan Biotech Target | YoY Change % |
|---|---|---|
| 2024 | ₹584.25 | [Current Price] |
| 2024 | ₹747.6 | 27.95% |
| 2025 | ₹1,071.21 | 43.28% |
| 2026 | ₹1,315.59 | 22.81% |
| 2027 | ₹1,670.02 | 26.94% |
| 2028 | ₹2,118.15 | 26.83% |
| 2029 | ₹2,312.98 | 9.19% |
| 2030 | ₹2,652.13 | 14.66% |
| 2031 | ₹2,814.7 | 6.12% |
| 2032 | ₹3,219.81 | 14.39% |
| 2033 | ₹3,776.09 | 17.27% |
| 2034 | ₹3,878.37 | 2.7% |
| 2035 | ₹4,233.06 | 9.14% |
| 2036 | ₹4,313.8 | 1.9% |
| 2037 | ₹4,769.6 | 10.56% |
| 2038 | ₹5,434.02 | 13.93% |
| 2039 | ₹5,418.75 | -0.29% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Titan Biotech Past Performance
- In 2000, Titan Biotech opening price was ₹15.5
- As of Fri 06 Sep 2024 the price stands at ₹584.25.
- This represents a Compound Annual Growth Rate (CAGR) of 15.62%.
- In 24 years, an investment of 10,000 would have become ₹3.76 Lakh.
As we wrap up, we hope you like our study on Titan Biotech share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
